Literature DB >> 29446740

Role of Immune Cells in Diabetic Kidney Disease.

Xiaoqian Yang1, Shan Mou1.   

Abstract

Diabetic Kidney Disease (DKD) is one of the major complications of Diabetes Mellitus (DM) and is currently the most common cause of End-Stage Renal Disease (ESRD) worldwide. Traditionally, DKD is considered a disease which has nothing to do with the immune system, and the pathogenesis is mainly characterized to be metabolic disturbance. Recent growing evidence indicates immunologic and inflammatory mechanisms in the development and progression of DKD. This overview of macrophages, dendritic cells, T lymphocytes, B lymphocytes, neutrophils and mast cells is closely involved in the pathologic process of DKD, with more emphasis on the leucocyte accumulation and related molecular mechanisms. Moreover, the potential contributions of these immune cells to renal injury will also be discussed. Specifically, these findings help to identify new potential therapeutic targets of DKD. Future preclinical and clinical studies might translate these exciting findings into clinical applications. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Diabetes mellitus.; Diabetic kidney disease; End stage renal disease; Immune cells; Pathogenesis; Therapeutic methods

Mesh:

Year:  2017        PMID: 29446740     DOI: 10.2174/1566523218666180214100351

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  6 in total

1.  Screening and Identification of Hub Genes in the Development of Early Diabetic Kidney Disease Based on Weighted Gene Co-Expression Network Analysis.

Authors:  Ran Wei; Jingtao Qiao; Di Cui; Qi Pan; Lixin Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

2.  Protective Effects of Thalidomide on High-Glucose-Induced Podocyte Injury through In Vitro Modulation of Macrophage M1/M2 Differentiation.

Authors:  Hui Liao; Yuanping Li; Xilan Zhang; Xiaoyun Zhao; Dan Zheng; Dayue Shen; Rongshan Li
Journal:  J Immunol Res       Date:  2020-08-27       Impact factor: 4.818

Review 3.  The Pathogenesis of End-Stage Renal Disease from the Standpoint of the Theory of General Pathological Processes of Inflammation.

Authors:  Evgenii Gusev; Liliya Solomatina; Yulia Zhuravleva; Alexey Sarapultsev
Journal:  Int J Mol Sci       Date:  2021-10-23       Impact factor: 5.923

4.  Hyperoside Suppresses Renal Inflammation by Regulating Macrophage Polarization in Mice With Type 2 Diabetes Mellitus.

Authors:  Jialing Liu; Yanmei Zhang; Hongqin Sheng; Chunling Liang; Huazhen Liu; Jose Alberto Moran Guerrero; Zhaoyu Lu; Wei Mao; Zhenhua Dai; Xusheng Liu; Lei Zhang
Journal:  Front Immunol       Date:  2021-12-03       Impact factor: 7.561

Review 5.  Long Non-Coding RNAs in the Pathogenesis of Diabetic Kidney Disease.

Authors:  Mengsi Hu; Qiqi Ma; Bing Liu; Qianhui Wang; Tingwei Zhang; Tongtong Huang; Zhimei Lv
Journal:  Front Cell Dev Biol       Date:  2022-04-20

Review 6.  MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.

Authors:  Hong Zhou; Wei-Jian Ni; Xiao-Ming Meng; Li-Qin Tang
Journal:  Front Cell Dev Biol       Date:  2021-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.